Avidity Biosciences, Inc. (RNA)
NASDAQ: RNA · Real-Time Price · USD
72.46
-0.18 (-0.25%)
Jan 28, 2026, 4:00 PM EST - Market closed

Avidity Biosciences Revenue

Avidity Biosciences had revenue of $12.48M in the quarter ending September 30, 2025, with 434.03% growth. This brings the company's revenue in the last twelve months to $20.87M, up 106.27% year-over-year. In the year 2024, Avidity Biosciences had annual revenue of $10.90M with 13.99% growth.

Revenue (ttm)
$20.87M
Revenue Growth
+106.27%
P/S Ratio
523.19
Revenue / Employee
$53,371
Employees
391
Market Cap
10.92B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202410.90M1.34M13.99%
Dec 31, 20239.56M336.00K3.64%
Dec 31, 20229.22M-102.00K-1.09%
Dec 31, 20219.33M2.54M37.41%
Dec 31, 20206.79M4.47M192.67%
Dec 31, 20192.32M1.94M511.87%
Dec 31, 2018379.00K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition